Policy

Legislative work

PSILORIS documents the countries where we are actively researching — and later advocating for — careful medical access to psilocybin. Australia is our worldwide reference model; South Africa is our first focus country.

Countries in focus

South Africa
Research & planning
PSILORIS is researching South Africa’s current scheduling, litigation, and policy landscape, and preparing a medical-access goal: reschedule psilocybin to Schedule 6 so authorised clinicians can issue a single prescription for up to 30 days of treatment with patient-specific dosing.

This section tracks PSILORIS's own policy work. For a broader snapshot of national status worldwide, see the legalization map.